CVS Sees a Possible Break-Even Point for GLP-1s
CVS white paper aims to pressure drugmakers to lower GLP-1 prices
CVS Health: 3 Key Takeaways for Long-Term Investors
CVS Health study highlights GLP-1 benefits and the affordability challenge
Merck or CVS: Only One Gets My Dividend Dollars for the Next 10 Years
CVS Health (CVS) Could Be 28% Undervalued As Its Recovery Narrative Builds
CVS Health (CVS) Wins Seven Stevie Awards For AI And Technology
CVS Pharmacy® launches latest collection of Caliber® Artist Series colleague-designed journals
Wells Fargo Maintains Overweight on CVS Health, Lowers Price Target to $112
CVS Beat Earnings by 27% and Split in Two, and Elizabeth Warren Says She Is Not Fooled
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
CVS Health earns global recognition for industry-leading AI and technology innovation
CVS Health Corporation (CVS) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript
What Is CVS Health (CVS) Signaling With Its Faster Biosimilar Push?
CVS Health (CVS) Stock Fair Value Edges Lower On Separation Risk And Analyst Caution
CVS Health’s Future Pharmacy CEO Just Bought $2 Million of Stock
All You Need to Know About CVS Health (CVS) Rating Upgrade to Buy
CVS Pharmacy(R) Makes Holiday Shopping Easier With Gifts for Every List, Budget and Celebration
CVS Caremark Is Expanding Access and Affordability With Biosimilars
Mark Cuban Says the CVS Breakup Is ‘Great for Shareholders.’ Here’s What It Means for a 67-Year-Old Who Bought 1,000 Shares the Day the Aetna Deal Closed
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.